HELP     Sign In
Search

Relevance to Autism

Kang et al., 2017 demonstrated that VRK3-deficient mice exhibited hyperactivity, stereotyped behaviors, reduced social interaction, impaired context-dependent spatial memory, reduced dendritic spine number and arborization in the CA1 region of the hippocampus, and altered synaptic transmission; these phenotypes could be reversed by TrkB stimulation with 7,8-dihydroxyflavone.

Molecular Function

This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. In both human and mouse, this gene has substitutions at several residues within the ATP binding motifs that in other kinases have been shown to be required for catalysis. In vitro assays indicate the protein lacks phosphorylation activity. The protein, however, likely retains its substrate binding capability. This gene is widely expressed in human tissues and its protein localizes to the nucleus. Inactive kinase that suppresses ERK activity by promoting phosphatase activity of DUSP3 which specifically dephosphorylates and inactivates ERK in the nucleus.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Autism-like behavior caused by deletion of vaccinia-related kinase 3 is improved by TrkB stimulation.
Support
High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population
DD, epilepsy/seizures

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN978R001a 
 splice_site_variant 
 c.139+2T>G 
  
 Familial 
 Both parents 
 Simplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
19
Duplication
 1
 
19
Deletion-Duplication
 20
 
19
Deletion-Duplication
 4
 
19
Duplication
 1
 

M_VRK3_1_KO_HM_DIHYDROXYFAVONE-2

Rescue Type: RESCUE-Pharmaceutical
Rescue Paradigm: Acute effect of 7,8-DHF, mice was measured at 24 h after three consecutive treatments with 7,8-DHF administered once a day. DHF was diluted in 17% DMSO to a final concentration of 10 mg/kg, and administered by intraperitoneal injection at a volume of 0.01 ml/g. For transient treatment, 7,8-DHF was administered to 12-wk-old mice once daily for three consecutive days, and mice were subjected to behavioral tests 1 and 7 d after treatment.

M_VRK3_1_KO_HM_DIHYDROXYFAVONE-2

Category
Entity
Effect on phenotype Qualification
Restored Treatment improves measured phenotype significantly
Refractory Treatment does not improve measured phenotype (was expected to do so)
Ameliorated Treatment provides partial correction or improvement of measured phenotype
No adverse effect Treatment does not affect the parameter adversely
Sustained effect Treatment has long term effect of restoration or amelioration, tested AFTER stopping administration (not applied for continuing long-term treatment) . Will be applied only where treatment has had restorative effects during administration or in the first battery of tests conducted.
No sustained effect Treatment has no long term of restoration or amelioration detectable, after stopping administration. Will be applied only where treatment has had restorative effects during administration or in the first battery of tests conducted.
Unexpected results Treats an unexpected phenotype
Side effect Exaggerates an unexpected phenotype
Experimental Paradigm
Age at Testing
Social approach1
Ameliorated
Description: 7,8-dhf treatment markedly recovered the impaired social interaction of mutant mice compared with dmso treatment but the effect was diminished 7 d after treatment.
Exp Paradigm: NA
 Three-chamber social approach test
 Adult
Social memory1
Refractory
Description: Dhf treatment failed to increased the time mutants spent with the novel stimulus mouse compared to the familiar mouse.
Exp Paradigm: NA
 Three-chamber social approach test
 Adult
Anxiety1
Refractory
Description: Acute treatments of 7,8-dhf failed to increase time spent in the open arms in the epm compared to controls.
Exp Paradigm: NA
 Elevated plus maze test
 Adult
Anxiety1
Refractory
Description: Acute treatments of 7,8-dhf failed to increase time spent in the center of the open field compared to controls.
Exp Paradigm: NA
 Open field test
 Adult
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory

M_VRK3_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
 General locomotor activity: ambulatory activity1
 Increased
Description: Mutants show increase in total distance travelled on the open field compared to controls.
Exp Paradigm: NA
 Open field test
 Not reported
 Post-synaptic density size1
 Decreased
Description: Mutants show reductions in psd length and thickness compared to controls.
Exp Paradigm: NA
 Electron microscopy
 3 months
 Dendritic architecture: spine density1
 Decreased
Description: Mutants show reductions in spine density in the ca1 and dentate gyrus regions with reductions in spine density in the ca1 more prominent on basal dendrites than apical dendrites.
Exp Paradigm: NA
 Golgi-cox staining
 3.25 months
 Neuroreceptor levels: trkb1
 Decreased
Description: Mutants show reduced levels of trkb compared to controls.
Exp Paradigm: NA
 Western blot
 3 months
 Dendritic architecture: dendritic tree complexity1
 Decreased
Description: Mutants show decreased dendritic arborization compared to controls.
Exp Paradigm: NA
 Sholl analysis
 3 months
 Neuroreceptor levels: glutamate receptors: nmda receptors1
 Increased
Description: Mutants show increased expression of glun1 compared to controls.
Exp Paradigm: NA
 Western blot
 3 months
 Dendritic architecture: dendritic length1
 Increased
Description: Mutants show increase in length of dendritic spines in all spine types of the ca1 region compared to controls.
Exp Paradigm: NA
 Golgi-cox staining
 3.25 months
 Neuroreceptor levels: glutamate receptors: ampa receptors1
 Decreased
Description: Mutants show decrease in glua1 in whole cell lysates compared to controls.
Exp Paradigm: NA
 Western blot
 1, 3 months
 Rectification of ion channels1
 Decreased
Description: Mutants show decrease in the ratio of ampa receptormediated currents measured at 40 and 70 mv holding potentials (also known as rectification), compared to controls, indicating a decreased proportion of ca ion-permeable ampa receptor in mutants.
Exp Paradigm: NA
 Whole-cell patch clamp
 Not reported
 Self grooming: perseveration1
 Increased
Description: Mutants spend more time grooming compared to controls.
Exp Paradigm: NA
 Grooming behavior assessments
 Not reported
 Social approach1
 Decreased
Description: Mutant and control mice had no preference for the right or left chambers during the habituation period of the three-chamber test. mutant mice did not show any preference for exploring a novel mouse-containing cage over a novel empty cage in a three-chamber test, compared to controls.
Exp Paradigm: NA
 Three-chamber social approach test
 Not reported
 Nest building behavior1
 Decreased
Description: Mutant mice show reduced shredding of nest building materials compared to controls.
Exp Paradigm: Nesting was scored on a scale of 0 to 3 based on the extent to which the nesting material was converted into fine pieces.
 Nest building assay
 Not reported
 Social memory1
 Decreased
Description: Mutant mice showed no preference for exploring the novel mouse over the familiar mouse compared to controls.
Exp Paradigm: NA
 Three-chamber social approach test
 Not reported
 Anxiety1
 Decreased
Description: Mutants spend more time in the open arms compared to controls.
Exp Paradigm: NA
 Elevated plus maze test
 Not reported
 Anxiety1
 Decreased
Description: Mutants spend more time in the light than control mice.
Exp Paradigm: NA
 Light-dark exploration test
 Not reported
 Anxiety1
 Decreased
Description: Mutants spend less time in the center of the field compared to controls.
Exp Paradigm: NA
 Open field test
 Not reported
 Spatial reference memory1
 Decreased
Description: Mutants mice had impaired spatial reference memory compared with wt mice as indicated by the decrease in the number of correct pokes during days 5 and 12 after training and the reduction in time spent at the target during probe trial when the escape hatch was removed.
Exp Paradigm: NA
 Barnes maze test
 Not reported
 Object recognition memory1
 Decreased
Description: Mutant mice exhibited a reduced ability to discriminate between familiar and novel objects at 24 h after training, compared to controls.
Exp Paradigm: NA
 Novel object recognition test
 Not reported
 Cued or contextual fear conditioning: passive avoidance1
 Increased
Description: Mutant mice show decrease in step-through latency compared to controls, after experiencing electric shock in a dark room. untrained mutant mice show no change in step-through latency compared to controls.
Exp Paradigm: NA
 Passive avoidance test
 Not reported
 Spatial working memory1
 Decreased
Description: Mutants mice had impaired spatial working memory compared with wt mice as indicated by increase in number of errors during the first 4 trial sessions on the barne's circular maze.
Exp Paradigm: NA
 Barnes maze test
 Not reported
 Maternal nurturing1
 Decreased
Description: Mutant nursing females take longer times to retrieve their pups compared to controls.
Exp Paradigm: NA
 Pup retrieval assay
 Not reported
 Protein expression level evidence1
 Increased
Description: Mutants show increased levels ofsynaptic protein arc expression compared to controls.
Exp Paradigm: NA
 Western blot
 3 months
 Protein phosphorylation1
 Decreased
Description: Mutants show decreased mtor and s6k phosphorylation compared to controls.
Exp Paradigm: NA
 Western blot
 3 months
 Protein expression level evidence1
 Decreased
Description: Mutants show decreased expression of synaptic proteins syntaxin, pak3, and psd-95 compared to controls.
Exp Paradigm: NA
 Western blot
 3 months
 Targeted expression1
 Decreased
Description: Mutants show absence of vrk3 protein and transcript compared to controls.
Exp Paradigm: Western blot
 Western blot
 Not reported
 Protein localization: synapse1
 Decreased
Description: Mutants show reduced levels of psd-95 and phosphorylated trkb in the synaptosomal fractions compared to controls. mutants show a slight reduction in glua1 in the synaptosomal fraction compared to controls.
Exp Paradigm: NA
 Western blot
 1, 3 months
 Targeted expression1
 Decreased
Description: Mutants show absence of vrk3 protein and transcript compared to controls.
Exp Paradigm: Quantitative pcr (qrt-pcr)
 Quantitative pcr (qrt-pcr)
 Not reported
 Protein localization: synapse1
 Increased
Description: Mutants show increase in levels of arc and phosphorylated camkiialpha in the psd fraction compared to controls.
Exp Paradigm: NA
 Western blot
 1, 3 months
 Protein phosphorylation1
 Increased
Description: Mutants show increase in camkiialpha and erk phosphorylation, compared to controls. mutants show increase in phosphorylated-erk/erk ratio compared to controls.
Exp Paradigm: NA
 Western blot
 3 months
Exploratory activity1
 No change
 Barnes maze test
 Not reported
Protein expression level evidence1
 No change
 Western blot
 3 months
Protein localization: synapse1
 No change
 Western blot
 1, 3 months
General locomotor activity: ambulatory activity1
 No change
 Elevated plus maze test
 Not reported
Dendritic architecture: dendritic length1
 No change
 Golgi-cox staining
 3.25 months
Dendritic architecture: spine morphology1
 No change
 Golgi-cox staining
 3.25 months
Neuroreceptor levels: glutamate receptors: ampa receptors1
 No change
 Western blot
 3 months
Neuroreceptor levels: glutamate receptors: mglur1
 No change
 Western blot
 3 months
Neuroreceptor levels: glutamate receptors: nmda receptors1
 No change
 Western blot
 3 months
Action potential property: firing rate1
 No change
 Whole-cell patch clamp
 Not reported
Epsp-spike relationship1
 No change
 Whole-cell patch clamp
 Not reported
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 Not reported
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 Not reported
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 Not reported
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 Not reported
Neurotransmitter release1
 No change
 Whole-cell patch clamp
 Not reported
Presynaptic function: paired-pulse facilitation1
 No change
 Whole-cell patch clamp
 Not reported
Spontaneous post synaptic event amplitude: excitatory currents1
 No change
 Whole-cell patch clamp
 Not reported
Spontaneous post synaptic event amplitude: inhibitory currents1
 No change
 Whole-cell patch clamp
 Not reported
Spontaneous post synaptic event frequency: excitatory currents1
 No change
 Whole-cell patch clamp
 Not reported
Spontaneous post synaptic event frequency: inhibitory currents1
 No change
 Whole-cell patch clamp
 Not reported
Synaptic neuroreceptor ratio (nmdar/ampar) dependent transmission1
 No change
 Whole-cell patch clamp
 Not reported
Synaptic plasticity: hippocampal ltd1
 No change
 Whole-cell patch clamp
 Not reported
Synaptic plasticity: hippocampal ltp1
 No change
 Whole-cell patch clamp
 Not reported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Physiological parameters, Seizure, Sensory

No PIN Data Available
HELP
Copyright © 2017 MindSpec, Inc.